Commission Implementing Regulation (EU) 2022/808 of 23 May 2022 amending Implementing Regulation (EU) No 540/2011 as regards the approval period of the active substance bispyribac
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
011/2023 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2022/808 of 23 May 2022 amending Implementing Regulation (EU) No 540/2011 as regards the approval period of the active substance bispyribac
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2022/808 frá 23. maí 2022 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar samþykkistímabil fyrir virka efnið bispýribak
Durchführungsverordnung (EU) 2022/808 der Kommission vom 23. Mai 2022 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Laufzeit der Genehmigung für den Wirkstoff Bispyribac
History
04.02.2023
Adopted JCD confirmed entry into force date
04.02.2023
Compliance date in the EEA
03.02.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
14.12.2022
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
23.05.2022
Adoption date in the EU
13.06.2022
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.